Cencora (COR) Shares Decline 2.21 % on Monday 26 November 2026

  • Closing Price – $331.00 per share at 10:03 AM Central Europe.
  • Volume – $386.7 million traded, representing 190.8 million shares outstanding.
  • Market Capitalisation – $63.2 billion.
  • Performance – Shares are down 2.21 % over the last 24 hours and up 6.82 % since the end of the previous month.
  • Technical Levels
  • 200‑day simple moving average: $317.43.
  • 52‑week high: $377.54 (25 November 2025).
  • 52‑week low: $244.82 (6 May 2026).
CompanyTicker24‑Hour ChangeCurrent PriceMarket CapitalisationP/E Ratio
Brookfield Asset ManagementBAM–1.28 %$47.03$75.1 billion27.39
O’Reilly AutomotiveORLY–2.26 %$89.92$72.7 billion28.73
Republic ServicesRSG–0.60 %$240.45$73.6 billion33.93
Hewlett Packard EnterpriseHPE+2.20 %$56.69$75.3 billion29.01
Royal Caribbean CruisesRCL–3.37 %$276.48$73.9 billion16.98

Recent Developments and Context

  • Pharmaceutical Market – The 2026 ESMO Congress reported new clinical data for Lilly’s investigational KRAS G12C inhibitor, olomorasib, combined with standard immunotherapy. The study shows durable efficacy in first‑line treatment of advanced non‑small cell lung cancer across all PD‑L1 expression levels, supporting the Phase III SUNRAY‑01 trial.
  • Education Commentary – A Malaysian education analysis highlights a disconnect between formal schooling and practical learning outcomes, suggesting a need for competency‑based curriculum reforms to prepare students for an AI‑driven economy.

About Cencora

Cencora, Inc. is a pharmaceutical company that provides end‑to‑end commercialization solutions, over‑the‑counter healthcare products, home healthcare supplies, equipment, and related services to healthcare providers. The company distributes its products internationally and operates its website at www.cencora.com . Cencora went public on April 4 1995 through the New York Stock Exchange.